Peter Jüni to Myocardial Infarction
This is a "connection" page, showing publications Peter Jüni has written about Myocardial Infarction.
Connection Strength
0.396
-
Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial. Eur Heart J. 2019 08 14; 40(31):2595-2604.
Score: 0.063
-
2018 ESC/EACTS Guidelines on myocardial revascularization. EuroIntervention. 2019 Feb 20; 14(14):1435-1534.
Score: 0.061
-
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial. Lancet. 2018 09 15; 392(10151):940-949.
Score: 0.059
-
The Compare-Acute trial of fractional flow reserve-guided multivessel angioplasty in myocardial infarction. EuroIntervention. 2017 08 04; 13(5):e613-e616.
Score: 0.055
-
Impact of stent overlap on long-term clinical outcomes in patients treated with newer-generation drug-eluting stents. EuroIntervention. 2014 Jan 22; 9(9):1076-84.
Score: 0.043
-
Restrictive compared with liberal red cell transfusion strategies in cardiac surgery: a meta-analysis. Eur Heart J. 2019 04 01; 40(13):1081-1088.
Score: 0.015
-
Fractional flow reserve-guided percutaneous coronary intervention vs. medical therapy for patients with stable coronary lesions: meta-analysis of individual patient data. Eur Heart J. 2019 01 07; 40(2):180-186.
Score: 0.015
-
Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial. Lancet. 2018 09 01; 392(10149):737-746.
Score: 0.015
-
Six-Month Outcomes after Restrictive or Liberal Transfusion for Cardiac Surgery. N Engl J Med. 2018 09 27; 379(13):1224-1233.
Score: 0.015
-
Five-Year Outcomes with PCI Guided by Fractional Flow Reserve. N Engl J Med. 2018 07 19; 379(3):250-259.
Score: 0.014
-
Cysteine-rich angiogenic inducer 61 (Cyr61): a novel soluble biomarker of acute myocardial injury improves risk stratification after acute coronary syndromes. Eur Heart J. 2017 Dec 14; 38(47):3493-3502.
Score: 0.014
-
Restrictive or Liberal Red-Cell Transfusion for Cardiac Surgery. N Engl J Med. 2017 11 30; 377(22):2133-2144.
Score: 0.014
-
Adverse events while awaiting myocardial revascularization: a systematic review and meta-analysis. Eur J Cardiothorac Surg. 2017 Aug 01; 52(2):206-217.
Score: 0.014